Search research articles
Contact Us
Filters
Showing results (201-210 of 240) with videos related to
Page
of 24
Sort By:
European Heart Journal
|
March 21, 2025
2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations I: therapy and prevention
Peter Jüni, Sotiris Antoniou, Elena Arbelo, et al.
European Journal of Heart Failure
|
December 3, 2020
Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium-glucose co-transporter 2 inhibitor therapy in DECLARE-TIMI 58
Thomas A Zelniker, David A Morrow, Ofri Mosenzon, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 31, 2021
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Emma F Magavern, Juan Carlos Kaski, Richard M Turner, et al.
Stroke
|
May 14, 2021
Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial
Jackie Bosch, Eva M Lonn, Gilles R Dagenais, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 27, 2021
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Emma Forton Magavern, Juan Carlos Kaski, Richard M Turner, et al.
Circulation
|
April 1, 2020
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial
Deepak L Bhatt, John W Eikelboom, Stuart J Connolly, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 9, 2019
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases
Gianluigi Savarese, Martin F Reiner, Alicia Uijl, et al.
Revista Espanola De Cardiologia (English Ed.)
|
May 22, 2021
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet, Holger Thiele, Emanuele Barbato, et al.
Circulation
|
March 18, 2020
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)
Kevin R Bainey, Robert C Welsh, Stuart J Connolly, et al.
European Heart Journal
|
August 30, 2020
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet, Holger Thiele, Emanuele Barbato, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 240) with videos related to
Sort By:
Page
of 24
European Heart Journal
|
March 21, 2025
2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations I: therapy and prevention
Peter Jüni, Sotiris Antoniou, Elena Arbelo, et al.
European Journal of Heart Failure
|
December 3, 2020
Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium-glucose co-transporter 2 inhibitor therapy in DECLARE-TIMI 58
Thomas A Zelniker, David A Morrow, Ofri Mosenzon, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 31, 2021
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Emma F Magavern, Juan Carlos Kaski, Richard M Turner, et al.
Stroke
|
May 14, 2021
Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial
Jackie Bosch, Eva M Lonn, Gilles R Dagenais, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 27, 2021
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Emma Forton Magavern, Juan Carlos Kaski, Richard M Turner, et al.
Circulation
|
April 1, 2020
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial
Deepak L Bhatt, John W Eikelboom, Stuart J Connolly, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 9, 2019
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases
Gianluigi Savarese, Martin F Reiner, Alicia Uijl, et al.
Revista Espanola De Cardiologia (English Ed.)
|
May 22, 2021
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet, Holger Thiele, Emanuele Barbato, et al.
Circulation
|
March 18, 2020
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)
Kevin R Bainey, Robert C Welsh, Stuart J Connolly, et al.
European Heart Journal
|
August 30, 2020
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet, Holger Thiele, Emanuele Barbato, et al.
Page
of 24